A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2011
03/30/2011	CN101991749A Preparation method of medicine for treating diabetes
03/30/2011	CN101991743A Traditional Chinese medicine for treating diabetic heart disease
03/30/2011	CN101991713A Medicament containing raw materials of Pu'er tea and worm grass
03/30/2011	CN101991674A Composition of safflower oil and hawthorn extracts and application thereof
03/30/2011	CN101991671A Traditional Chinese medicine for treating diabetic eye disease
03/30/2011	CN101991670A Alpha-gluconase activity inhibiter and application thereof in preparation of diabetic medicament
03/30/2011	CN101991651A Medicament for quenching thirst and preparation method thereof
03/30/2011	CN101991648A Traditional Chinese medicine for treating diabetic coronary heart disease
03/30/2011	CN101991647A Traditional Chinese medicine for treating diabetic coronary heart diseases
03/30/2011	CN101991646A Traditional Chinese medicine for treating diabetic diarrhea
03/30/2011	CN101991644A Composition of safflower oil and salvia extracts and application thereof
03/30/2011	CN101991635A Preparation method of chickpea total saponin
03/30/2011	CN101991627A Application of ginsenoside components to preparation of medicaments for inhibiting activity of alpha-glucosidase
03/30/2011	CN101991624A Method for preparing total asiatic acid, asiatic acid and madecassic acid from asiatic pennywort herb and use of prepared product
03/30/2011	CN101991622A Preparation process of Nitraria schoberi L seed oil liposome
03/30/2011	CN101991614A Compound fermented cordyceps sinensis powder (paecilomyces hepiali Cs-4 bacterial powder) combined medicine and preparation thereof
03/30/2011	CN101991606A Preparation method of solid water-soluble lead-removed propolis
03/30/2011	CN101991604A Forest frog oil capsules and preparation method
03/30/2011	CN101991597A Applications of oral pharmaceutical composition to preparation of medicament for preventing or treating kidney diseases
03/30/2011	CN101991593A Application of quercetin in medicament preparation
03/30/2011	CN101991590A Stilbene glucoside medical composite and preparation method thereof
03/30/2011	CN101991580A Application of lanostane and poria cocos extracts in diabetes treatment
03/30/2011	CN101991578A Application of asiatic acid and madecassic acid in preparation of alpha-glucosidase inhibitor drugs
03/30/2011	CN101991573A Corynoxeine and application of isomer thereof in preparing medicines
03/30/2011	CN101991572A Novel dipeptidyl peptidase IV inhibitor
03/30/2011	CN101991567A Application of three biflavone monomer components extracted from ginkgo leaves in preparing medicament of alpha-glucosidase inhibitor
03/30/2011	CN101991566A Application of lariciresinol to preparing medicament for resisting autoimmune disease and graft rejection disease
03/30/2011	CN101991547A Preparation method of sodium ferulate freeze-dried powder injection
03/30/2011	CN101991535A Docosahexaenoic acid (DHA) ester fat emulsion intravenous injection and manufacturing method thereof
03/30/2011	CN101991534A EPA (eicoeapentaenoieaeid) ester fat emulsion intravenous injection and preparation method thereof
03/30/2011	CN101991532A Self-microemulsion composition, microemulsion and preparation methods thereof
03/30/2011	CN101991127A Powdery mixture containing phytosterol and oryzanol and preparation method thereof
03/30/2011	CN101991107A method for preparing sesame honey paste
03/30/2011	CN101991099A Ginseng can
03/30/2011	CN101990971A Method for preparing Indian buead persimmon leaf tea
03/30/2011	CN101990969A Weight reducing tea and preparation method thereof
03/30/2011	CN101637573B Medicinal composition for treating diabetes and preparation method thereof
03/30/2011	CN101637491B Health-care food having functions of assisting antidiabetics and assisting antiatheroscloresis, and preparation method thereof
03/30/2011	CN101579471B Medicine for curing diabetes
03/30/2011	CN101569614B Puerarin lagging cover slowly-releasing dripping pill and preparing method thereof
03/30/2011	CN101416950B Preparation method of cmellia sponin controlled release tablets
03/30/2011	CN101375872B Novel medicament prescription for treating diabetes
03/30/2011	CN101352483B Medicine for treating diabetes
03/30/2011	CN101327203B Gallic acid chelates composition and uses thereof
03/30/2011	CN101309746B Method for production of single- and multi-layer microcapsules
03/30/2011	CN101235061B Novel alpha-amylase inhibitor alcaftadine series compounds and application thereof
03/30/2011	CN101229264B Chinese traditional medicine prescription and preparation of active ingredient thereof
03/30/2011	CN101214319B Chinese medicine health care products capable of regulating blood fat and preparation thereof
03/30/2011	CN101209084B Pet beverage containing active peptide and preparation method thereof
03/30/2011	CN101111508B Spiroketal derivative and use thereof as diabetic medicine
03/30/2011	CN101103993B Hypoglycemic medicine composition
03/30/2011	CN101077098B Weight losing tea
03/30/2011	CN101032323B Functionality foods including ginger oil resin
03/30/2011	CN101007790B Oxamic acid derivative, and its preparation method and medicinal uses
03/29/2011	US7915420 Aryl piperidine amides
03/29/2011	US7915310 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate
03/29/2011	US7915280 Compounds and their uses
03/29/2011	US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same
03/29/2011	US7915265 Combinations for the treatment of immunoinflammatory disorders
03/29/2011	US7915252 Sulfonyl compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
03/29/2011	US7915234 Pharmaceutically active uridine esters
03/29/2011	US7914537 Devices and methods for the restoration of a spinal disc
03/29/2011	CA2620065C Methods and formulations for modulating lyn kinase activity and treating related disorders
03/29/2011	CA2618857C 11-beta-hydroxysteroid dehydrogenase-1-inhibitor-diabetes-type 2-1
03/29/2011	CA2497237C N-substituted-2-oxodihydropyridine derivatives
03/29/2011	CA2494892C Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
03/29/2011	CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011	CA2472114C 2-o-(.beta.-d-glucopyranosyl) ascorbic acid, process for its production, and foods and cosmetics containing compositons comprising it
03/29/2011	CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
03/29/2011	CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
03/29/2011	CA2443672C Aryl and biaryl piperidines used as mch antagonists
03/29/2011	CA2436764C Rehydration composition
03/29/2011	CA2435730C Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
03/29/2011	CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/29/2011	CA2420562C Creatine ester pronutrient compounds and formulations
03/29/2011	CA2383779C N-(indolecarbonyl)piperazine derivatives
03/29/2011	CA2381992C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
03/29/2011	CA2331071C A colostrum food composition and method of using same
03/24/2011	WO2011035110A2 Treatment for oxidative stress and/or hypertension
03/24/2011	WO2011034951A2 Assisted enzyme replacement therapy
03/24/2011	WO2011034834A2 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same
03/24/2011	WO2011034532A1 Stilbene-based compositions and methods of use therefor
03/24/2011	WO2011034396A2 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion
03/24/2011	WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
03/24/2011	WO2011034166A1 Anti-obesity agent, anti-obesity food or beverage, glucose tolerance-ameliorating agent, and food or beverage for amelioration of glucose tolerance
03/24/2011	WO2011034078A1 Glycine compound
03/24/2011	WO2011034051A1 Novel cyclic squaramide derivatives
03/24/2011	WO2011033255A1 (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use
03/24/2011	WO2011033225A2 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof
03/24/2011	WO2011033099A1 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia
03/24/2011	WO2011033055A1 Fused triazole amines as p2x7 modulators
03/24/2011	WO2011032502A1 Plant extract, compositons containing same, method of extraction and uses thereof
03/24/2011	WO2011032360A1 Momordica charantia peptide mc-jj2 and microwave promoted solid phase synthesis method thereof
03/24/2011	WO2011032359A1 Momordica charantia peptide mc-jj6 and microwave promoted solid phase synthesis method thereof
03/24/2011	WO2011032320A1 Novel alkene oxindole derivatives
03/24/2011	WO2011013141A3 Substituted benzamide derivatives as glucokinase (gk) activators
03/24/2011	WO2010140765A3 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
03/24/2011	WO2010132562A3 Transdermal delivery of metformin
03/24/2011	WO2010129048A3 Therapeutic compounds
03/24/2011	US20110071225 Method for obtaining a sequoyitol-containing extract from genus nephrolepis and uses thereof

1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 1298